𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Calcium hydroxyapatite promotes mitogenesis and matrix metalloproteinase expression in human breast cancer cell lines

✍ Scribed by Maria P. Morgan; Michelle M. Cooke; Pamela A. Christopherson; Pamela R. Westfall; Geraldine M. McCarthy

Publisher
John Wiley and Sons
Year
2001
Tongue
English
Weight
228 KB
Volume
32
Category
Article
ISSN
0899-1987

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

Radiographic mammary microcalcifications are one of the most pertinent diagnostic markers of breast cancer. Breast tissue calcification in the form of calcium hydroxyapatite (HA) is strongly associated with malignant disease. We tested the hypothesis that calcium HA may exert biological effects on surrounding cells, thereby facilitating breast cancer progression. Our findings showed that HA crystals enhanced mitogenesis in breast cancer cell lines MCF‐7 and Hs578T and also in normal human mammary epithelial cells. HA crystals were also found to upregulate the production of a variety of matrix metalloproteinases (MMPs), including MMP‐2, ‐9, and ‐13 in MCF‐7 and MMP‐9 in human mammary epithelial cell lines. HA crystals were found to greatly augment prostaglandin E~2~ levels in Hs578T cells, and treatment with a cyclooxygenase inhibitor, aspirin, abrogated the HA‐induced mitogenesis. These results suggest that calcium HA crystals may play an active role in amplifying the pathological process involved in breast cancer. Β© 2001 Wiley‐Liss, Inc.

πŸ“œ SIMILAR VOLUMES

Nuclear matrix proteins in well and poor
Nuclear matrix proteins in well and poorly differentiated human breast cancer cell lines
✍ Shanti K. Samuel; Travis M. Minish; James R. Davie πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 175 KB πŸ‘ 2 views

The nuclear matrix, besides providing the structural support of the nucleus, is involved in various cellular functions of the nucleus. Nuclear matrix proteins (NMPs), which are both tissue-and cell type-specific, are altered with transformation and state of differentiation. Furthermore, NMPs have be

Novel inhibitors of urokinase-type plasm
Novel inhibitors of urokinase-type plasminogen activator and matrix metalloproteinase expression in metastatic cancer cell lines
✍ Kristina Cakarovski; Jenny Y. Leung; Christina Restall; Anna Carin-Carlson; Euni πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 French βš– 339 KB πŸ‘ 1 views

## Abstract The plasminogen‐activating (PA) and matrix metalloproteinase (MMP) enzyme systems are implicated in proteolytic turnover of the extracellular matrix (ECM) associated with biologic processes including wound healing, inflammation and angiogenesis. Aberrant expression of components of the

Expression and tyrosine phosphorylation
Expression and tyrosine phosphorylation of EMS1 in human breast cancer cell lines
✍ Douglas H. Campbell; Anna deFazio; Robert L. Sutherland; Roger J. Daly πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 French βš– 1018 KB

The EMS1 gene encodes an 80185 kDa C-src substrate and localises with the CCNDl gene to chromosome I lq13. This locus is amplified in approximately 13% of human breast cancers. E M S I gene amplification and expression were charactensed in a panel of human breast cancer cell lines to determine at wh

Immunological characterization of cell-s
Immunological characterization of cell-surface and soluble forms of membrane type 1 matrix metalloproteinase in human breast cancer cells and in fibroblasts
✍ Hui Li; Delbert E. Bauzon; Xinyun Xu; Harald Tschesche; Jian Cao; QingXiang Amy πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 242 KB πŸ‘ 1 views

Membrane type (MT) 1 matrix metalloproteinase (MMP) activates progelatinase A (pro-MMP-2), a type IV collagenase, on the cell surface of tumors; however, its function in breast cancer progression and metastasis is not fully understood. To examine the expression of MT1-MMP in breast cancer cells and